Condition: Post-stroke Cognitive Impairment · Sponsor: Simcere Pharmaceutical Co., Ltd
This is a multicenter, randomized, double-blind, placebo-controlled, exploratory Phase II clinical trial. The goal of this clinical trial is to assess the safety and efficacy of edaravone dexborneol sublingual tablets for post-stroke cognitive impairment in patients with acute ischemic stroke. Participants will be required to receive 24 weeks treatment of edaravone dexborneol sublingual tablets or placebo during this study. The safety and efficacy endpoints will be compared in the patients with edaravone dexborneol sublingual tablets or placebo.
This description comes directly from the study's public registry record.
Chunchen Huang, Doctor · +8618502113382 · huangchunchen@simcere.com
Always discuss trial participation with your own doctor first.
| Taihe County People's Hospital | Fuyang, Anhui, China | Recruiting |
| Hefei First People's Hospital | Hefei, Anhui, China | Recruiting |
| The First Affiliated Hospital of USTC Anhui Provincial Hospital | Hefei, Anhui, China | Recruiting |
| The Second People's Hospital of Hefei | Hefei, Anhui, China | Recruiting |
| Huangshan City People's Hospital | Huangshan City, Anhui, China | Recruiting |
| The Second Affiliated Hospital of Guangzhou Medical University | Guangzhou, Guangdong, China | Recruiting |
| Wuzhou Red Cross Hospital | Wuzhou, Guangxi, China | Recruiting |
| The Second Hospital of Hebei Medical University | Shijiazhuang, Hebei, China | Recruiting |
| Zhumadian Central Hospital | Zhumadian, Henan, China | Recruiting |
| The Second Affiliated Hospital of Nanchang University | Nanchang, Jiangxi, China | Recruiting |
| The First Hospital of Jilin University | Changchun, Jilin, China | Recruiting |
| Liaoning Health Industry Group Bensteel General Hospital | Benxi, Liaoning, China | Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06315231